Administration route-dependent pharmacokinetic and biopharmaceutical features of steppogenin

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Pharmaceutical Investigation

• Publication date

  2025-02-06

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s40005-025-00730-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer

  2024cited by this paper
• Matrix effects in ultra-high performance supercritical fluid chromatography-mass spectrometry analysis of vitamin E in plasma: The effect of sample preparation and data processing.

  2024cited by this paper
• In Vitro Metabolism and Transport Characteristics of Zastaprazan

  2024cited by this paper
• Pharmacokinetics and extensive intestinal first-pass effects of apigenin and its active metabolite, apigenin-7-O-glucuronide, in rats

  2024cited by this paper
• Exploring pharmacokinetics and herb-drug interactions of an herbal extract mixture derived from Poria cocos and Morus alba L.

  2024cited by this paper
• Toxicokinetics and tissue distribution of phalloidin in mice.

  2023cited by this paper
• Effects of red ginseng extract on the pharmacokinetics and disposition of warfarin via intestinal Cyp2c11 modulation in rats

  2023cited by this paper
• The Bioavailability of Drugs—The Current State of Knowledge

  2023cited by this paper
• Recent Advances in Potential Health Benefits of Quercetin

  2023cited by this paper
• Toxicokinetics of β-Amanitin in Mice and In Vitro Drug–Drug Interaction Potential

  2022cited by this paper
• Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients

  2022cited by this paper
• Concomitant Administration of Red Ginseng Extract with Lactic Acid Bacteria Increases the Plasma Concentration of Deglycosylated Ginsenosides in Healthy Human Subjects

  2022influential reference
• Steppogenin suppresses tumor growth and sprouting angiogenesis through inhibition of HIF-1α in tumors and DLL4 activity in the endothelium.

  2022influential reference
• Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method

  2022cited by this paper
• Model yeast as a versatile tool to examine the antioxidant and anti-ageing potential of flavonoids, extracted from medicinal plants

  2022cited by this paper
• Pharmacokinetics and Tissue Distribution of Enavogliflozin in Mice and Rats

  2022cited by this paper
• Transport and Interactions of Co-incubated Bi-functional Flavonoids through Inhibiting the Function of P-Glycoprotein (P-gp) Using KB/Multidrug-Resistant (MDR) Cells and Rat Everted Gut Sacs.

  2022cited by this paper
• Polyphenols and Human Health: The Role of Bioavailability

  2021cited by this paper
• Kuwanon T and Sanggenon A Isolated from Morus alba Exert Anti-Inflammatory Effects by Regulating NF-κB and HO-1/Nrf2 Signaling Pathways in BV2 and RAW264.7 Cells

  2021cited by this paper
• Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability

  2021cited by this paper
• Flavonoids Targeting HIF-1: Implications on Cancer Metabolism

  2021cited by this paper
• Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism

  2020cited by this paper
• Anticancer Activity of Natural Flavonoids: Inhibition of HIF-1α Signaling Pathway

  2020cited by this paper
• The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin

  2020influential reference
• Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronic Acid Conjugates on Cytochrome P450 Enzymes, and on OATP, BCRP and MRP2 Transporters

  2020cited by this paper
• Morin as an imminent functional food ingredient: an update on its enhanced efficacy in the treatment and prevention of metabolic syndromes.

  2020cited by this paper
• Safety and pharmacokinetics of naringenin: A randomized, controlled, single‐ascending‐dose clinical trial

  2019influential reference
• Regulating intracellular ROS signal by a dual pH/reducing-responsive nanogels system promotes tumor cell apoptosis

  2019cited by this paper
• Quercetin: A Flavonol With Versatile Therapeutic Applications and Its Interactions With Other Drugs

  2019cited by this paper
• Effects of verapamil on the pharmacokinetics of dihydromyricetin in rats and its potential mechanism

  2018cited by this paper
• Flavonoids in fruits and vegetables after thermal and nonthermal processing: A review

  2018cited by this paper
• Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update

  2018cited by this paper
• Steppogenin Isolated from Cudrania tricuspidata Shows Antineuroinflammatory Effects via NF-κB and MAPK Pathways in LPS-Stimulated BV2 and Primary Rat Microglial Cells

  2017cited by this paper
• Characterization, in Vivo and in Vitro Evaluation of Solid Dispersion of Curcumin Containing d-α-Tocopheryl Polyethylene Glycol 1000 Succinate and Mannitol

  2016influential reference
• Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5′-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography–Tandem Mass Spectrometry

  2015cited by this paper
• Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases.

  2015cited by this paper
• Transport characteristics and transporter‐based drug–drug interactions of TM‐25659, a novel TAZ modulator

  2014influential reference
• Evaluation of Inhibitory Effects of Caffeic acid and Quercetin on Human Liver Cytochrome P450 Activities

  2014influential reference
• Flavonoid Bioavailability and Attempts for Bioavailability Enhancement

  2013cited by this paper
• Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban

  2013influential reference
• Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin.

  2011cited by this paper
• Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.

  2011influential reference
• Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.

  2009cited by this paper
• In vivo hypoglycemic effects of phenolics from the root bark of Morus alba.

  2009cited by this paper
• Mechanism of CYP2C9 Inhibition by Flavones and Flavonols

  2009cited by this paper
• Matrix effect elimination during LC-MS/MS bioanalytical method development.

  2009cited by this paper
• Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.

  2007influential reference
• A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma.

  2006influential reference
• High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.

  2005cited by this paper
• Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol

  2005cited by this paper
• Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol.

  2005cited by this paper
• Chemistry and pharmacology of the citrus bioflavonoid hesperidin

  2001cited by this paper

• Comparative Evaluation and Improvement of the Analytical Method for Amiodarone Hydrochloride: Replacing the Pharmacopeial Method with a Validated RP-HPLC Technique

  2026cites this paper
• The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma

  2025cites this paper
• Reverse translational approach to clarify the strong potency of enavogliflozin, a novel sodium-glucose cotransporter 2 inhibitor.

  2025cites this paper